A detailed history of Pictet Asset Management Sa transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 4,666,813 shares of BLUE stock, worth $39.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,666,813
Previous 3,104,751 50.31%
Holding current value
$39.7 Million
Previous $9.87 Million 55.5%
% of portfolio
0.02%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$2.79 - $5.03 $4.36 Million - $7.86 Million
1,562,062 Added 50.31%
4,666,813 $15.4 Million
Q1 2023

May 10, 2023

BUY
$3.14 - $8.22 $6.32 Million - $16.6 Million
2,013,689 Added 184.56%
3,104,751 $9.87 Million
Q4 2022

Feb 13, 2023

BUY
$5.77 - $8.49 $1.58 Million - $2.33 Million
273,984 Added 33.53%
1,091,062 $7.55 Million
Q3 2022

Nov 14, 2022

BUY
$3.75 - $7.39 $390,776 - $770,089
104,207 Added 14.62%
817,078 $5.17 Million
Q2 2022

Aug 09, 2022

BUY
$2.94 - $5.23 $1.19 Million - $2.12 Million
406,212 Added 132.46%
712,871 $2.95 Million
Q1 2022

May 13, 2022

BUY
$4.07 - $10.6 $299,397 - $779,757
73,562 Added 31.56%
306,659 $1.49 Million
Q4 2021

Feb 10, 2022

BUY
$8.96 - $16.31 $390,234 - $710,349
43,553 Added 22.98%
233,097 $2.33 Million
Q3 2021

Nov 12, 2021

BUY
$11.24 - $21.0 $2.13 Million - $3.98 Million
189,544 New
189,544 $3.62 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $656M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.